Cargando…
Endovascular renal denervation: a novel sympatholytic with relevance to chronic kidney disease
Endovascular renal denervation (sympathectomy) is a novel procedure developed for the treatment of resistant hypertension. Evidence suggests that it reduces both afferent and efferent sympathetic nerve activity, which may offer clinical benefit over and above any blood pressure-lowering effect. Stud...
Autores principales: | Hoye, Neil A., Baldi, James C., Putt, Tracey L., Schollum, John B., Wilkins, Gerard T., Walker, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389153/ https://www.ncbi.nlm.nih.gov/pubmed/25859344 http://dx.doi.org/10.1093/ckj/sft130 |
Ejemplares similares
-
Endovascular Renal Denervation in End-Stage Kidney Disease Patients: Cardiovascular Protection—A Proof-of-Concept Study
por: Hoye, Neil A., et al.
Publicado: (2017) -
Central sympatholytics prolong survival in experimental sepsis
por: Hofer, Stefan, et al.
Publicado: (2009) -
Renal denervation reduces atrial remodeling in hypertensive rats with metabolic syndrome
por: Selejan, Simina-Ramona, et al.
Publicado: (2022) -
Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition
por: Herat, Lakshini Y., et al.
Publicado: (2022) -
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
por: DeFronzo, Ralph A.
Publicado: (2011)